Praxis Precision Medicines (PRAX) Depreciation and Depletion (2019 - 2026)
Praxis Precision Medicines' (PRAX) quarterly Depreciation and Depletion came in at $39000.0 in Q1 2026, down 17.02% year-on-year from $47000.0 in Q1 2025, and up 425.0% quarter-over-quarter from -$12000.0 in Q4 2025.
Praxis Precision Medicines (PRAX) Depreciation and Depletion (2019 - 2026) Analysis & Trends
Praxis Precision Medicines' Depreciation and Depletion history runs 8 years deep, the most recent figure standing at $39000.0 for Q1 2026.
- On a quarterly basis, Depreciation and Depletion fell 17.02% year-over-year to $39000.0 in Q1 2026; TTM through Mar 2026 was $92000.0, a 68.6% decrease from a year earlier, with the FY2025 full-year figure at $100000.0, down 72.07% from the prior year.
- Depreciation and Depletion advanced to $39000.0 in Q1 2026 per PRAX's latest filing, from -$12000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $119000.0 in Q2 2022 and bottomed at -$12000.0 in Q4 2025.
- The 5-year median for Depreciation and Depletion is $92000.0 (2024), against an average of $76294.1.
- Across the five-year window, Depreciation and Depletion jumped 340.74% in 2022 and slumped 125.53% in 2025, its largest moves.
- Year by year, Depreciation and Depletion stood at $86000.0 in 2022, then retreated by 8.14% to $79000.0 in 2023, then sank by 40.51% to $47000.0 in 2024, then slumped by 125.53% to -$12000.0 in 2025, then soared by 425.0% to $39000.0 in 2026.
- Per Business Quant, the three latest PRAX Depreciation and Depletion figures stand at $39000.0 (Q1 2026), -$12000.0 (Q4 2025), and $19000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Praxis Precision Medicines | 8.98 Bn | 8.20 Bn | - | 39,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39,000.00 |
| Mar 31, 2026 | 39,000.00 |
| Dec 31, 2025 | -12,000.00 |
| Dec 31, 2025 | -12,000.00 |
| Sep 30, 2025 | 19,000.00 |
| Sep 30, 2025 | 19,000.00 |
| Jun 30, 2025 | 46,000.00 |
| Jun 30, 2025 | 46,000.00 |
| Mar 31, 2025 | 47,000.00 |
| Mar 31, 2025 | 47,000.00 |
| Dec 31, 2024 | 47,000.00 |
| Dec 31, 2024 | 47,000.00 |
| Sep 30, 2024 | 92,000.00 |
| Sep 30, 2024 | 92,000.00 |
| Jun 30, 2024 | 107,000.00 |
| Jun 30, 2024 | 107,000.00 |
| Mar 31, 2024 | 112,000.00 |
| Mar 31, 2024 | 112,000.00 |
| Dec 31, 2023 | 79,000.00 |
| Dec 31, 2023 | 79,000.00 |